Literature DB >> 15157564

Adipocyte biology and adipocytokines.

Wasim A Haque1, Abhimanyu Garg.   

Abstract

Adipose tissue actively participates in regulation of food intake, energy expenditure, fuel metabolism, and a variety of other physiologic processes through its endocrine, paracrine, and autocrine secretory products (Table 4). Abnormal synthesis of these secretory products may be related to the pathogenesis of insulin resistance and its complications in patients who have adipose tissue disorders, such as obesity and lipodvstrophies.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15157564     DOI： 10.1016/j.cll.2004.01.007

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN： 0272-2712            Impact factor:   1.935


  8 in total

1.  Blasts from the past.

Authors:  Paul A Insel; Stuart Kornfeld; Philip W Majerus; Andrew R Marks; Paul A Marks; Arnold S Relman; Bruce F Scharschmidt; Thomas P Stossel; Ajit P Varki; Stephen J Weiss; Jean D Wilson
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

2.  Comparison of the clinical efficacy of medical treatment of symptomatic benign prostatic hyperplasia between normal and obese patients.

Authors:  Seung Hwan Lee; Cheol Young Oh; Kyung Kgi Park; Mun Su Chung; Se Jeong Yoo; Byung Ha Chung
Journal:  Asian J Androl       Date:  2011-04-18       Impact factor: 3.285

Review 3.  Abnormalities of Reproductive Function in Male Obesity Before and After Bariatric Surgery-A Comprehensive Review.

Authors:  Alberto Rosenblatt; Joel Faintuch; Ivan Cecconello
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

4.  Insulin prevents leptin inhibition of RM1 prostate cancer cell growth.

Authors:  Andreia M Ribeiro; Sofia Pereira; Sara Andrade; Madalena Costa; Carlos Lopes; Artur P Aguas; Mariana P Monteiro
Journal:  Pathol Oncol Res       Date:  2011-11-24       Impact factor: 3.201

5.  Prostate cancer cell proliferation and angiogenesis in different obese mice models.

Authors:  Andreia M Ribeiro; Sara Andrade; Filipa Pinho; J Duarte Monteiro; Madalena Costa; Carlos Lopes; Artur P Aguas; Mariana P Monteiro
Journal:  Int J Exp Pathol       Date:  2010-08       Impact factor: 1.925

6.  Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial.

Authors:  Miguel F Herrera; Juan Pablo Pantoja; David Velázquez-Fernández; Javier Cabiedes; Carlos Aguilar-Salinas; Eduardo García-García; Alfredo Rivas; Christian Villeda; Diego F Hernández-Ramírez; Andrea Dávila; Aarón Zaraín
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 17.152

7.  Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.

Authors:  Jeannette M Schenk; Alan R Kristal; Marian L Neuhouser; Catherine M Tangen; Emily White; Daniel W Lin; Ian M Thompson
Journal:  Prostate       Date:  2009-09-01       Impact factor: 4.104

8.  Measuring the improvement in health-related quality of life using King's health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study.

Authors:  Jae Heon Kim; Hoon Choi; Hwa Yeon Sun; Seung Whan Doo; Jong Hyun Yoon; Won Jae Yang; Byung Wook Yoo; Joyce Mary Kim; Soon-Sun Kwon; Eun Seop Song; Hong Jun Lee; Ik Sung Lim; Yun Seob Song
Journal:  BMC Urol       Date:  2014-08-06       Impact factor: 2.264
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.